Melanotan Ii vs PT-141 for libido
Short answer: For libido, users rate them about the same: 96% report improvement with Melanotan Ii (47 reports) and 94% with PT-141 (63 reports).
Melanotan Ii has 1 meta-analyses and 1 randomized trials on PubMed; PT-141 has 0 and 4.
Based on 145 reports about Melanotan Ii and 103 about PT-141. Not medical advice.
| Melanotan Ii Peptide | PT-141 Peptide | |
|---|---|---|
| User score | 61 | 56 |
| Verdict | Mostly positive | Mixed |
| Positive of reports that state an outcome | 63% | 55% |
| Reports | 145 | 103 |
| Research | BResearch: Moderate | CResearch: Limited |
| Meta-analyses / RCTs | 1 / 1 | 0 / 4 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (11) | — |
| Appetite % reporting improvement | 67% (6) | — |
| Sleep % reporting improvement | 0% (4) | — |
| Mood % reporting improvement | 40% (5) | 67% (3) |
| Performance % reporting improvement | 100% (5) | 100% (8) |
| Libido % reporting improvement | 96% (47) | 94% (63) |
| Heart & lipids % reporting improvement | 33% (3) | — |
| Skin & hair % reporting improvement | 91% (67) | — |
| Immunity % reporting improvement | 100% (2) | — |
| Common side effects | nausea, flushing, freckles, darkened moles | nausea, headache, flushing, prolonged erection |
| Typical dose reported | Not listed | Not listed |
Melanotan IiFull Melanotan Ii profile →
Latest review conclusion
Almost all studies are in the preclinical phase. There are currently no effective clinical treatments for MC4R-deficient obese patients, although MC4R agonists are being developed and are entering phase I and II trials.
Int J Obes (Lond), 2014 ↗What a user said
“I've found that getting sun within 3-12 hours will produce the desired result.”
PT-141Full PT-141 profile →
What a user said
“I take pt141 with cialis and it works great for me. Pt141 works great alone and I only need to take 1mg.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate